Cambria Investment Management’s Emergent Biosolutions EBS Stock Holding History

Cambria Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Buy	+34,039	New	+$285K	0.01%	615

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Cambria Investment Management's EBS Position: Q2 2026 in Review

Cambria Investment Management opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 34,039 shares worth $285K. The stake represents 0.01% of the portfolio and ranks #615 among its holdings.

195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Cambria Investment Management held 34,039 shares of Emergent Biosolutions worth $285K as of Q2 2026.
Emergent Biosolutions was a new Cambria Investment Management position in Q2 2026.
Emergent Biosolutions made up 0.01% of Cambria Investment Management's portfolio in Q2 2026, its #615 holding.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.